These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28824294)

  • 1. Involvement of Ornithine Carbamoyltransferase in the Progression of Chronic Hepatitis C and Liver Cirrhosis.
    Ohnishi M; Higuchi A; Matsumura H; Arakawa Y; Nakamura H; Nirei K; Yamamoto T; Yamagami H; Ogawa M; Gotoda T; Matsuoka S; Nakajima N; Sugitani M; Moriyama M; Murayama H
    Int J Med Sci; 2017; 14(7):629-638. PubMed ID: 28824294
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical evaluation of serum ornithine carbamoyltransferase by enzyme-linked immunosorbent assay in patients with liver diseases.
    Watanabe Y; Mori S; Fujiyama S; Sato T; Mori M
    Enzyme Protein; 1994-1995; 48(1):18-26. PubMed ID: 7787967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ratio of serum ornithine carbamoyltransferase to alanine aminotransferase as a potent indicator for hepatocellular carcinoma.
    Murayama H; Fukuda Y; Tsunekawa S; Ikemoto M; Nagata A
    Clin Biochem; 2007 Sep; 40(13-14):1077-80. PubMed ID: 17570354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating intercellular adhesion molecule-1 in chronic liver disease and hepatocellular carcinoma.
    Huang YS; Wu JC; Chan CY; Chao Y; Chang FY; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Aug; 62(8):487-95. PubMed ID: 10462824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of human intercellular adhesion molecule 1 in the blood is useful for predicting the occurrence of hepatocellular carcinomas from chronic hepatitis C and liver cirrhosis.
    Moriyama M; Matsumura H; Shioda J; Aoki H; Nakamura H; Arakawa Y; Nirei K; Yamagami H; Kaneko M; Tanaka N; Arakawa Y
    Intervirology; 2006; 49(6):327-38. PubMed ID: 16926545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients.
    Motawi TK; Shaker OG; El-Maraghy SA; Senousy MA
    PLoS One; 2015; 10(9):e0137706. PubMed ID: 26352740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
    Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I
    Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating vascular adhesion protein-1(VAP-1): a possible biomarker for liver fibrosis associated with chronic hepatitis B and C.
    Öksüz Z; Üçbilek E; Serin MS; Yaraş S; Temel GO; Sezgin O
    Braz J Microbiol; 2020 Dec; 51(4):1757-1763. PubMed ID: 32959205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum DHCR24 Auto-antibody as a new Biomarker for Progression of Hepatitis C.
    Ezzikouri S; Kimura K; Sunagozaka H; Kaneko S; Inoue K; Nishimura T; Hishima T; Kohara M; Tsukiyama-Kohara K
    EBioMedicine; 2015 Jun; 2(6):604-12. PubMed ID: 26288822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of serum galectin-3 levels in patients with hepatocellular cancer and chronic viral hepatitis.
    Ulu M; Alacacioglu A; Yuksel E; Pamukk BO; Bozkaya G; Ari A; Yuksel A; Sop G; Alacacioglu I
    Saudi J Gastroenterol; 2015; 21(1):47-50. PubMed ID: 25672239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of ornithine carbamoyltransferase as a biomarker of liver cirrhosis.
    Matsushita N; Hashimoto E; Tokushige K; Kodama K; Tobari M; Kogiso T; Torii N; Taniai M; Shiratori K; Murayama H
    Intern Med; 2014; 53(12):1249-57. PubMed ID: 24930642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C-viral chronic liver diseases.
    Yamagamim H; Moriyama M; Matsumura H; Aoki H; Shimizu T; Saito T; Kaneko M; Shioda A; Tanaka N; Arakawa Y
    Cancer; 2002 Aug; 95(4):824-34. PubMed ID: 12209727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
    Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
    PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma nitrites/nitrates in HCV infection and hepatocellular carcinoma.
    Moussa YI; Plevris JN; Hayes PC
    Eur J Gastroenterol Hepatol; 2000 Feb; 12(2):159-63. PubMed ID: 10741929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
    Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI
    Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma.
    Sun Y; Zhu S; Wu Z; Huang Y; Liu C; Tang S; Wei L
    Oncotarget; 2017 Apr; 8(14):23427-23435. PubMed ID: 28178643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corelation of serum alpha fetoprotein and tumor size in hepatocellular carcinoma.
    Abbasi A; Bhutto AR; Butt N; Munir SM
    J Pak Med Assoc; 2012 Jan; 62(1):33-6. PubMed ID: 22352098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum concentration of E-selectin in patients with chronic hepatitis, liver cirrhosis and hepatocellular carcinoma.
    Cervello M; Virruso L; Lipani G; Giannitrapani L; Soresi M; Carroccio A; Gambino R; Sanfililippo R; Marasà L; Montalto G
    J Cancer Res Clin Oncol; 2000 Jun; 126(6):345-51. PubMed ID: 10870645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C.
    Kitaoka S; Shiota G; Kawasaki H
    Hepatogastroenterology; 2003; 50(53):1569-74. PubMed ID: 14571788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.